NewEdge Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.35M Sell
13,746
-166
-1% -$64.6K 0.03% 545
2025
Q1
$6.05M Buy
13,912
+2,531
+22% +$1.1M 0.04% 447
2024
Q4
$4.2M Sell
11,381
-3,275
-22% -$1.21M 0.03% 560
2024
Q3
$7.62M Buy
14,656
+292
+2% +$152K 0.05% 352
2024
Q2
$7.78M Buy
14,364
+2,492
+21% +$1.35M 0.06% 327
2024
Q1
$6.16M Sell
11,872
-1,955
-14% -$1.01M 0.05% 338
2023
Q4
$6.52M Sell
13,827
-121
-0.9% -$57.1K 0.06% 294
2023
Q3
$6.07M Buy
13,948
+1,045
+8% +$455K 0.07% 280
2023
Q2
$5.73M Buy
12,903
+1,191
+10% +$529K 0.06% 289
2023
Q1
$5.38M Sell
11,712
-3,805
-25% -$1.75M 0.07% 284
2022
Q4
$3.84M Sell
15,517
-3,695
-19% -$913K 0.1% 215
2022
Q3
$8.73M Buy
19,212
+2,972
+18% +$1.35M 0.14% 161
2022
Q2
$7.84M Buy
16,240
+817
+5% +$394K 0.13% 167
2022
Q1
$7.58M Buy
15,423
+6,784
+79% +$3.33M 0.12% 170
2021
Q4
$4M Buy
8,639
+3,390
+65% +$1.57M 0.06% 293
2021
Q3
$1.96M Buy
5,249
+49
+0.9% +$18.3K 0.05% 325
2021
Q2
$1.99M Buy
5,200
+1,241
+31% +$474K 0.05% 314
2021
Q1
$1.42M Buy
3,959
+178
+5% +$63.9K 0.04% 365
2020
Q4
$1.21M Buy
3,781
+95
+3% +$30.5K 0.04% 372
2020
Q3
$990K Sell
3,686
-221
-6% -$59.4K 0.03% 388
2020
Q2
$1.03M Sell
3,907
-73
-2% -$19.2K 0.04% 346
2020
Q1
$904K Buy
3,980
+1,269
+47% +$288K 0.04% 330
2019
Q4
$819K Buy
2,711
+58
+2% +$17.5K 0.03% 401
2019
Q3
$642K Buy
2,653
+632
+31% +$153K 0.03% 425
2019
Q2
$570K Sell
2,021
-120
-6% -$33.8K 0.03% 370
2019
Q1
$615K Buy
2,141
+458
+27% +$132K 0.04% 354
2018
Q4
$442 Buy
1,683
+413
+33% +$108 0.03% 398
2018
Q3
$348K Buy
+1,270
New +$348K 0.03% 456